Apec Policy Dialogue and Workshop on Attaining A

Apec Policy Dialogue and Workshop on Attaining A

APEC POLICY DIALOGUE AND WORKSHOP ON ATTAINING A SAFE AND SUSTAINABLE BLOOD SUPPLY CHAIN Asian Institute of Management, Manila, Philippines 30 September – 1 October 2014 Workshop Chairs Updated 19 September 2014 Prof. Maureen Goodenow, Workshop Chair, Department of State and the University of Florida, United States Maureen M. Goodenow, Ph.D. is Professor of Pathology, Immunology, and Laboratory Medicine in the College of Medicine at the University of Florida. She holds the Stephany W. Holloway Endowed Chair for HIV/AIDS Research and is the Director of the Center for Research in Pediatric Immune Deficiency. Professor Goodenow has a research program in molecular epidemiology, pathogenesis, and vaccines for HIV-1 and related viruses, such as human papillomaviruses that cause cancer. Her research involves implementation of technology, including high-throughput next generation genomics, bioinformatics and systems biology, to solve problems of human-pathogen interactions from a global health perspective. Her interests include the role of governments in developing and implementing global health policies and how security and economics influence global health policy and programs. Professor Goodenow received a Ph.D. in molecular genetics from the Sue Golding Graduate School at the Albert Einstein College of Medicine in New York. Following a postdoctoral fellowship in molecular oncology at the Sloan Kettering Institute in New York, she was a visiting scientist at the Pasteur Institute in Paris before accepting a faculty position at the University of Florida in the College of Medicine. She has published over 100 articles and book chapters, serves on the editorial boards of numerous journals, was appointed as a special advisor to the Vice Chancellor of Research for the City University of New York, advises the NIH on merits of scientific proposals and the Trans-NIH Plan for HIV-Related Research in the Office of AIDS Research, and is a former member of the AIDS Research Advisory Committee for the Division of AIDS in the National Institute of Allergy and Infectious Diseases at NIH. She provided advice to the combined program between NIH and Department of State for enhancing research between US and Russian scientists, as well as to Fogarty Programs in India and Kazakhstan and to medical fellowship training programs in Brazil. In 2012, Dr. Goodenow was selected as a Jefferson Science Fellow, a prestigious program for senior academic scientists to provide advice at the Department of State and the National Academies of Sciences. Currently she continues as a Senior Advisor for Health, Science, Technology, and Innovation at the Department of State in the Office of Economic Policy in the Bureau of East Asia Pacific Affairs [EAP/EP], the lead office for US engagement in APEC [Asia Pacific Economic Cooperation], where her expertise is applied to a portfolio of projects related to the economics of health and universal health care, higher education, science/ technology and innovation, as well as economic advantages for increasing roles for women and facilitating travel mobility for business, research, and higher education. Her APEC-related activities included organizing interagency working groups, participating in bilateral meetings with APEC economies, serving as US government lead at High Level Meetings for Health and the Economy attended by ministers of health from Asia Pacific region, and co-organizing international policy dialogues on HIV-1, health-care associated infections, multi-drug resistance tuberculosis, mental health, and cervical cancer. During her year at the Department of State, Professor Goodenow presented in the Jefferson Science Fellow Lecture Series a lecture about PEPFAR as a model for global health diplomacy. 1 APEC POLICY DIALOGUE AND WORKSHOP ON ATTAINING A SAFE AND SUSTAINABLE BLOOD SUPPLY CHAIN Asian Institute of Management, Manila, Philippines 30 September – 1 October 2014 Dr. Kenneth Hartigan-Go, Acting Director General, Food and Drug Administration, Department of Health, Philippines On August 23, 2012, Dr. Kenneth Y. Hartigan-Go was appointed Director IV of the Food and Drug Administration by H. E. Benigno Simeon C. Aquino. Dr. Hartigan-Go has more than 20 years of experience as a clinician, professor, and manager of health programs. Dr. Hartigan-Go also has over ten years’ experience in management positions—as executive director of the Zuellig Foundation, a major health foundation which focuses on health leadership and management, community health partnerships, health governance and health policy, and as deputy director of the Philippine Department of Health Bureau of Food and Drug and National Drug Policy units. Dr. Hartigan-Go maintains extensive links into the Philippine and international business and health governance communities. Dr. Hartigan-Go has served as an advisor and consultant to USAID, the WHO and the European Community. 2 APEC POLICY DIALOGUE AND WORKSHOP ON ATTAINING A SAFE AND SUSTAINABLE BLOOD SUPPLY CHAIN Asian Institute of Management, Manila, Philippines 30 September – 1 October 2014 Speaker Biographies (listed alphabetically by last name) Dr. Maria Victoria Abesamis, OIC Executive Director, Philippine Blood Disease and Transfusion Center, Department of Health, Philippines Dr. Ang Ai Leen, Deputy Group Director, Blood Services Group, Health Sciences Authority, Singapore Dr Ang Ai Leen (MBBS, MRCP (UK), FRCPath (UK) ) is the Deputy Group Director of Blood Services Group at Health Sciences Authority, which is responsible for collecting, processing and distributing blood and blood components to all hospitals in Singapore. Dr Ang received her medical education at the National University of Singapore. After graduating in 2001, she continued to receive her Basic Specialist Training (Internal medicine) and Advanced Specialist Training (Haematology) in Singapore. She was granted registration as a specialist in Haematology by the Specialist Accreditation Board (Singapore) since 2008. Dr Ang has keen interests in promoting safe and effective clinical transfusion, and is active in the promotion of Patient Blood Management in Singapore. She also holds concurrent position as a Consultant at the Department of Haematology in Singapore General Hospital where she serves in its Hospital Transfusion Committee. She is actively involved in the undergraduate education of Yong Loo Lin School of Medicine as well as postgraduate education for Dukes-NUS Graduate Medical School, Haematology Residency and Advanced Specialist Traineeship, especially in the fields of clinical transfusion and red cell haematology. Prof Elizabeth Arcellana-Nuqui, Consultant Specialist, Department of Health, Philippines Doctor of Medicine: University of the Philippines PROFESSIONAL LICENSURES: Philippine Board of Medicine Education Council for Foreign Medical Graduates (ECFMG), 1970 US Federal Licensure Examination (FLEX) (State of New York), 1976 SPECIALTY BOARDS: Diplomate, Anatomic and Clinical Pathology American Board of Pathology, November 1975 Diplomate, Anatomic and Clinical Pathology Philippine Board of Pathology, January 1977 PROFESSIONAL ORGANIZATIONS: Fellow, College of American Pathologists since 1982 Fellow, Philippine Society of Pathologists, since 1981 3 APEC POLICY DIALOGUE AND WORKSHOP ON ATTAINING A SAFE AND SUSTAINABLE BLOOD SUPPLY CHAIN Asian Institute of Management, Manila, Philippines 30 September – 1 October 2014 Fellow, Philippine Society of Oncologists Fellow, International Academy of Pathology Affiliate Fellow, Society of Gynecologic Oncologists of the Philippines Member, American Association of Blood Banks, 1999, 2000, 2001, 2004 SOME RECENT AND CURRENT POSITIONS: Professor of Pathology, College of Medicine, University of the Philippines, 1997 – 2011 (retired) Chairperson, Department of Pathology, College of Medicine, University of the Philippines, 1994 – 1998 President, Philippine Blood Coordinating Council, 1999, 2000, 2005 to 2007 President, Philippine Society of Oncologists, 2003 Chair, Committee on Professional Education, National Council for Blood Services, since 2005 Consultant, Department of Health, National Voluntary Blood Services Program, since 2000 Vice-President, Philippine Council for Quality Assurance of Clinical Laboratories. 2013- present Dr. Yasmin Ayob, Visiting Consultant, National Blood Centre, Kuala Lumpur Malaysia Currently, Dr Yasmin Ayob serves as a visiting consultant at the National Blood Centre in Kuala Lumpur and the National Heart Institute as well as Honorary Lecturer at the Advance Medical and Dental Institute, Universiti Sains Malaysia(AMDI/USM). She was the first Director of the National Blood Centre from 2000 to 2008. During that time she helped reorganized the blood programme, set up the first public cord blood bank, introduced NAT testing, established Transfusion Medicune as a stand alone speciality, and initiated the Masters Programme in Transfusion Medicine and Transfusion Science at AMDI/USM. She is on the Panel of Expert in Transfusion Medicine of the World Health Organisation since 2000, which includes serving as Temporary Advisor in various countries. She was also on the editorial board of Transfusion Medicine. She has also served as member of the Board of Director of the International Society of Blood Transfusion (ISBT) in 2000-2006. She is currently the President of the Malaysian Blood Transfusion Society and Vice-President of the Haemohilia Society of Malaysia. For contribution, she has been given awards nationally and internationally, that include the ISBT Award in 2009.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    25 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us